Development and Validation of the COVID-19 Knowledges and Behavior Questionnaire in a French Population (CoVQuest-CC)

Elise Verot, Paul Bonjean, Robin Chaux, Julie Gagnaire, Amandine Gagneux-Brunon, Bruno Pozzetto, Philippe Berthelot, Elisabeth Botelho-Nevers and Franck Chauvin
Additional contact information
Elise Verot: Laboratoire Parcours Santé Systémique, Université Claude Bernard Lyon 1, Université de Lyon, P2S UR 4129, F-69008 Lyon, France
Paul Bonjean: Unité de Recherche Clinique, Innovation, Pharmacologie, Hôpital Nord, Centre Hospitalier Universitaire de Saint-Étienne, F-42055 Saint-Etienne, France
Robin Chaux: Unité de Recherche Clinique, Innovation, Pharmacologie, Hôpital Nord, Centre Hospitalier Universitaire de Saint-Étienne, F-42055 Saint-Etienne, France
Julie Gagnaire: Team GIMAP, CIRI—Centre International de Recherche en Infectiologie, Université Jean Monnet, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F-42023 Saint-Etienne, France
Amandine Gagneux-Brunon: Team GIMAP, CIRI—Centre International de Recherche en Infectiologie, Université Jean Monnet, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F-42023 Saint-Etienne, France
Bruno Pozzetto: Team GIMAP, CIRI—Centre International de Recherche en Infectiologie, Université Jean Monnet, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F-42023 Saint-Etienne, France
Philippe Berthelot: Team GIMAP, CIRI—Centre International de Recherche en Infectiologie, Université Jean Monnet, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F-42023 Saint-Etienne, France
Elisabeth Botelho-Nevers: Team GIMAP, CIRI—Centre International de Recherche en Infectiologie, Université Jean Monnet, Université de Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F-42023 Saint-Etienne, France
Franck Chauvin: Laboratoire Parcours Santé Systémique, Université Claude Bernard Lyon 1, Université de Lyon, P2S UR 4129, F-69008 Lyon, France

IJERPH, 2022, vol. 19, issue 5, 1-22

Abstract: Background: The SARS-CoV-2 pandemic has led most countries to take restrictive measures affecting social activities and individual freedoms to limit viral transmission. It was shown that practical, motivational and social barriers impact on adherence to the isolation and social distancing measures advocated by the health authorities. The purpose of this study was to develop and validate a COVID-19 Knowledges and Behavior Questionnaire adapted to a teenager and adult French population. Methods: CoVQuest-CC was developed by a multidisciplinary team made of infectious diseases physicians, medical virologist, specialists of infectious control, experts of the questionnaires methodology, experts in public health and prevention, and statisticians. CoVQuest-CC was responded to by a big cohort from the general population during their participation in a massive SARS-CoV-2 screening campaign in 2021 in Saint-Etienne, France. Results: The confirmatory factorial analysis yielded good results (CFI = 0.94, TLI = 0.94, RMSEA = 0.04), and confirmed the five-dimensional structure of the questionnaire. Each dimension had a satisfying internal consistency, with Cronbach alphas of 0.83, 0.71, 0.65, 0.72 and 0.83 for transmission knowledge, barrier gesture respect, tests acceptability, home isolation possibility and test practicability, respectively. Conclusions: According to our knowledge, CoVQuest-CC is the first validated, consistent and reliable self-administrated French-specific questionnaire investigating the general population’s knowledge and attitudes towards COVID-19. It shows acceptable psychometric properties and can be use by Public Health teams or caregivers for public health and research purposes. Trial Registration: The study protocol was approved by the IRB ILE-DE-FRANCE 1 (No. IRB: I ORG0009918). All participants were given written and verbal information about the study and gave informed consent to participate. ClinicalTrials.gov identifier (NCT number): NCT04859023.

Keywords: COVID-19; SARS-CoV-2; health literacy; behaviors; questionnaire; mass screening (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/5/2569/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/5/2569/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:5:p:2569-:d:756410

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().